• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼古丁代谢物比率作为香烟消费量的预测指标。

Nicotine metabolite ratio as a predictor of cigarette consumption.

作者信息

Benowitz Neal L, Pomerleau Ovide F, Pomerleau Cynthia S, Jacob Peyton

机构信息

Department of Medicine, University of California San Francisco, San Francisco, CA 94143-1220, USA.

出版信息

Nicotine Tob Res. 2003 Oct;5(5):621-4. doi: 10.1080/1462220031000158717.

DOI:10.1080/1462220031000158717
PMID:14577978
Abstract

The rate of nicotine metabolism is hypothesized to be a determinant of how much a person smokes. That is, rapid metabolizers would be expected to need more nicotine and, therefore, smoke more than slow metabolizers. Nicotine is metabolized extensively by the liver enzyme CYP2A6, primarily to cotinine. Cotinine is itself metabolized by CYP2A6 to 3'-hydroxycotinine (3-HC). The ratio of metabolite to parent (i.e., 3-HC:cotinine) would be expected to reflect CYP2A6 activity. We measured the ratio of 3-HC:cotinine in the urine of 72 smokers. This ratio was significantly correlated with the number of cigarettes smoked per day (r=.33, p=.005), though not with the Fagerström Test for Nicotine Dependence. This finding supports the hypothesis that the rate of nicotine metabolism is a determinant of the level of cigarette consumption and supports the use of the 3-HC:cotinine ratio as a noninvasive marker of nicotine metabolism.

摘要

尼古丁代谢速率被假定为一个人吸烟量的决定因素。也就是说,预计尼古丁快速代谢者比缓慢代谢者需要更多尼古丁,因此吸烟更多。尼古丁主要通过肝脏酶CYP2A6广泛代谢为可替宁。可替宁自身又被CYP2A6代谢为3'-羟基可替宁(3-HC)。代谢物与母体的比例(即3-HC:可替宁)预计能反映CYP2A6的活性。我们测量了72名吸烟者尿液中3-HC:可替宁的比例。该比例与每日吸烟支数显著相关(r = 0.33,p = 0.005),但与尼古丁依赖的法格斯特龙测试无关。这一发现支持了尼古丁代谢速率是香烟消费水平决定因素的假说,并支持将3-HC:可替宁比例用作尼古丁代谢的非侵入性标志物。

相似文献

1
Nicotine metabolite ratio as a predictor of cigarette consumption.尼古丁代谢物比率作为香烟消费量的预测指标。
Nicotine Tob Res. 2003 Oct;5(5):621-4. doi: 10.1080/1462220031000158717.
2
Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.在日本男性人群中,每日吸烟后,尿可替宁浓度与烟碱代谢物血浆水平的生物监测。
Int J Environ Res Public Health. 2010 Jul;7(7):2953-64. doi: 10.3390/ijerph7072953. Epub 2010 Jul 20.
3
Nicotine Dependence and Urinary Nicotine, Cotinine and Hydroxycotinine Levels in Daily Smokers.日常吸烟者的尼古丁依赖与尿中尼古丁、可替宁和羟基可替宁水平
Nicotine Tob Res. 2016 Sep;18(9):1813-9. doi: 10.1093/ntr/ntw099. Epub 2016 Apr 15.
4
Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers.年轻成年每日吸薄荷醇和非薄荷醇香烟者的尼古丁代谢
Nicotine Tob Res. 2016 Apr;18(4):437-46. doi: 10.1093/ntr/ntv109. Epub 2015 May 19.
5
Determinants of the rate of nicotine metabolism and effects on smoking behavior.尼古丁代谢速率的决定因素及其对吸烟行为的影响。
Clin Pharmacol Ther. 2006 Oct;80(4):319-30. doi: 10.1016/j.clpt.2006.06.011.
6
Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults.多种族/多民族全国青年样本中的尿液尼古丁代谢物与吸烟行为
Am J Epidemiol. 2007 Apr 15;165(8):901-10. doi: 10.1093/aje/kwm010. Epub 2007 Feb 23.
7
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.自由吸烟和减少吸烟人群中尼古丁代谢物比率的稳定性。
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1396-400. doi: 10.1158/1055-9965.EPI-08-0242.
8
Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.尼古丁代谢物比值与一组暴露和效应生物标志物的关系:来自两项美国商业卷烟吸烟者研究的结果。
Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):871-879. doi: 10.1158/1055-9965.EPI-19-0644. Epub 2020 Feb 12.
9
Nicotine intake and smoking topography in smokers with bipolar disorder.双相障碍吸烟者的尼古丁摄入量和吸烟特征。
Bipolar Disord. 2012 Sep;14(6):618-27. doi: 10.1111/j.1399-5618.2012.01047.x.
10
Nicotine metabolite ratio predicts smoking topography: The Pennsylvania Adult Smoking Study.尼古丁代谢物比值可预测吸烟特征:宾夕法尼亚州成人吸烟研究。
Drug Alcohol Depend. 2018 Sep 1;190:89-93. doi: 10.1016/j.drugalcdep.2018.06.003. Epub 2018 Jul 4.

引用本文的文献

1
Tobacco, nicotine, and cannabis use and exposure in an Australian Indigenous population during pregnancy: A protocol to measure parental and foetal exposure and outcomes.澳大利亚原住民人群在妊娠期间的烟草、尼古丁和大麻使用及暴露情况:测量父母和胎儿暴露及结局的方案。
PLoS One. 2024 Sep 6;19(9):e0300406. doi: 10.1371/journal.pone.0300406. eCollection 2024.
2
Associating CYP2A6 structural variants with ovarian and lung cancer risk in the UK Biobank: replication and extension.在英国生物银行中将CYP2A6结构变异与卵巢癌和肺癌风险相关联:复制与扩展
Eur J Hum Genet. 2024 Mar;32(3):357-360. doi: 10.1038/s41431-023-01518-2. Epub 2023 Dec 14.
3
Relationships Between the Nicotine Metabolite Ratio and Laboratory Assessments of Smoking Reinforcement and Craving Among Adults in a Smoking Cessation Trial.
戒烟试验中成年人尼古丁代谢物比率与吸烟强化及渴望的实验室评估之间的关系
Nicotine Tob Res. 2024 Apr 22;26(5):604-611. doi: 10.1093/ntr/ntad232.
4
Changes and stability of hand nicotine levels in children of smokers: Associations with urinary biomarkers, reported child tobacco smoke exposure, and home smoking bans.吸烟者儿童手部尼古丁水平的变化和稳定性:与尿液生物标志物、报告的儿童烟草烟雾暴露和家庭禁烟令的关联。
Environ Int. 2023 Nov;181:108239. doi: 10.1016/j.envint.2023.108239. Epub 2023 Sep 27.
5
CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian Randomization study.CYP2A6 与呼吸疾病风险和诊断年龄较小有关:全表型关联孟德尔随机化研究。
Hum Mol Genet. 2024 Jan 7;33(2):198-210. doi: 10.1093/hmg/ddad172.
6
Effects of Short-term Electronic(e)-Cigarette Aerosol Exposure in the Mouse Larynx.短期电子(e)-香烟气溶胶暴露对小鼠喉部的影响。
Laryngoscope. 2024 Mar;134(3):1316-1326. doi: 10.1002/lary.31043. Epub 2023 Sep 12.
7
Society for Research on Nicotine and Tobacco as an Outgrowth of the 1988 Surgeon General's Report on Nicotine Addiction: Reflections of the Early Presidents.作为《1988 年美国卫生总监关于尼古丁成瘾的报告》的衍生组织,美国国家药物滥用研究所烟草研究学会的历任主席:思考与回顾。
Nicotine Tob Res. 2024 Jan 22;26(2):118-125. doi: 10.1093/ntr/ntad151.
8
The use of biomarkers to guide precision treatment for tobacco use.使用生物标志物指导烟草使用的精准治疗。
Addict Neurosci. 2023 Jun;6. doi: 10.1016/j.addicn.2023.100076. Epub 2023 Feb 16.
9
Genotyping, characterization, and imputation of known and novel CYP2A6 structural variants using SNP array data.利用 SNP 芯片数据进行已知和新型 CYP2A6 结构变异的基因分型、特征分析和推断。
J Hum Genet. 2023 Aug;68(8):533-541. doi: 10.1038/s10038-023-01148-y. Epub 2023 Apr 14.
10
Examining racial differences in smoking outcomes among smokers enrolled in an intravenous nicotine infusion study.检查静脉尼古丁输注研究中吸烟者吸烟结果的种族差异。
Addict Behav. 2023 May;140:107615. doi: 10.1016/j.addbeh.2023.107615. Epub 2023 Jan 9.